Published on: 2025-06-27 21:04:00
Glucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have recently gained popularity globally, not just for managing type 2 diabetes but also due to their weight loss benefits. This increase in popularity is mainly due to celebrity endorsements and the power of social media. According to a research letter published in August 2024, between January 2021 and December 2023, the number of semaglutide fills increased by 442%. Ozempic accounte
Keywords: agonists diabetes doctor doctors glp
Find related items on AmazonGo K’awiil is a project by nerdhub.co that curates technology news from a variety of trusted sources. We built this site because, although news aggregation is incredibly useful, many platforms are cluttered with intrusive ads and heavy JavaScript that can make mobile browsing a hassle. By hand-selecting our favorite tech news outlets, we’ve created a cleaner, more mobile-friendly experience.
Your privacy is important to us. Go K’awiil does not use analytics tools such as Facebook Pixel or Google Analytics. The only tracking occurs through affiliate links to amazon.com, which are tagged with our Amazon affiliate code, helping us earn a small commission.
We are not currently offering ad space. However, if you’re interested in advertising with us, please get in touch at [email protected] and we’ll be happy to review your submission.